Daurismo Side Effects
Generic name: glasdegib
Medically reviewed by Drugs.com. Last updated on Mar 10, 2025.
Note: This document provides detailed information about Daurismo Side Effects associated with glasdegib. Some dosage forms listed on this page may not apply specifically to the brand name Daurismo.
Applies to glasdegib: oral tablet.
Important warnings
This medicine can cause some serious health issues
Oral route (tablet)
Warning: Embryo-Fetal Toxicity. Glasdegib can cause embryo-fetal death or severe birth defects when administered to a pregnant woman.
Glasdegib is embryotoxic, fetotoxic, and teratogenic in animals.
Conduct pregnancy testing in females of reproductive potential prior to initiation of glasdegib treatment.
Advise females of reproductive potential to use effective contraception during treatment with glasdegib and for at least 30 days after the last dose.
Advise males of the potential risk of glasdegib exposure through semen and to use condoms with a pregnant partner or a female partner of reproductive potential during treatment with glasdegib and for at least 30 days after the last dose to avoid potential drug exposure.
Precautions
It is very important that your doctor check your progress at regular visits while you are using this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it. Blood and urine tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. It may also cause birth defects if the father is using it when his sexual partner becomes pregnant. Female patients should use effective birth control during treatment with this medicine and for at least 30 days after the last dose. Male patients who have female partners should use effective birth control (even after a vasectomy) during treatment with this medicine and for at least 30 days after the last dose. If you think you have become pregnant while using this medicine, tell your doctor right away.
Your doctor will give you a pregnancy test within 7 days before you use this medicine to make sure you are not pregnant.
Do not donate blood or blood products or sperm while you are using this medicine and for at least 30 days after the last dose.
Contact your doctor right away if you have any changes to your heart rhythm. You might feel dizzy or faint, or you might have a fast, pounding, or uneven heartbeat. Make sure your doctor knows if you had a heart rhythm problem, such as QT prolongation.
If you plan to have children, talk with your doctor before using this medicine. Some men using this medicine have become infertile (unable to have children).
Cancer medicines can cause diarrhea, nausea, vomiting, or stomach pain in most people, sometimes even after receiving medicines to prevent it. Ask your doctor or nurse about other ways to control these unwanted effects.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Serious side effects of Daurismo
Along with its needed effects, glasdegib (the active ingredient contained in Daurismo) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking glasdegib:
More common side effects
- black, tarry stools
- bleeding gums
- blood in the urine or stools
- chest pain
- chills
- confusion
- cough
- coughing up blood
- decreased frequency or amount of urine
- difficult or labored breathing
- difficulty in swallowing
- dizziness or fainting
- drowsiness
- dry mouth
- fainting
- fast, slow, or irregular heartbeat
- fever
- headache
- increased blood pressure
- increased menstrual flow or vaginal bleeding
- increased thirst
- lightheadedness
- loss of appetite
- loss of consciousness
- lower back or side pain
- mood or mental changes
- muscle pain or cramps
- muscle spasms (tetany) or twitching seizures
- nausea
- nervousness
- nosebleeds
- numbness or tingling in the hands, feet, or lips
- painful or difficult urination
- pale skin
- paralysis
- pinpoint red spots on the skin
- pounding heartbeat
- prolonged bleeding from cuts
- rapid, shallow breathing
- red or black, tarry stools
- red or dark brown urine
- seizures
- sneezing
- sore throat
- stomach pain
- swelling of the face, hands, ankles, or lower legs
- tightness in the chest
- trembling
- troubled breathing with exertion
- ulcers, sores, or white spots in the mouth
- unusual bleeding or bruising
- unusual tiredness or weakness
- vomiting
- weakness or heaviness of the legs
- weight gain
Other side effects of Daurismo
Some side effects of glasdegib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bone or muscle pain
- change in taste
- constipation
- cracked lips
- decreased appetite
- diarrhea
- loose tooth
- loss of taste
- skin rash
- thinning or loss of hair
- toothache
For healthcare professionals
Applies to glasdegib: oral tablet.
Hematologic adverse events
- Very common (10% or more): Anemia (43%), hemorrhage (e.g., petechiae, epistaxis, hematoma, contusion, rectal hemorrhage, anal hemorrhage, ecchymosis, gingival bleeding, hematuria, mouth hemorrhage, purpura, cerebral hemorrhage, eye contusion, eye hemorrhage, gastric hemorrhage, GI hemorrhage, hematemesis, hemoptysis, implant site hematoma, injection site bruising, retroperitoneal hematoma, thrombotic thrombocytopenic purpura, tracheal hemorrhage, conjunctival hemorrhage, disseminated intravascular coagulation, eyelid hematoma, hematochezia, hemorrhage intracranial, hemorrhoidal hemorrhage, lower GI hemorrhage, retinal hemorrhage, subdural hematoma) (36%), febrile neutropenia (31%0, thrombocytopenia (30%), platelet count decreased (15%), white blood cell count decreased (11%)[Ref]
Musculoskeletal
- Very common (10% or more): Musculoskeletal pain (e.g., pain in extremity, arthralgia, back pain, myalgia, musculoskeletal pain, musculoskeletal chest pain, neck pain, bone pain (30%), creatine phosphokinase (CPK) increased (16%), muscle tightness/spasm (15%)[Ref]
Metabolic
- Very common (10% or more): Hyponatremia (54%), hypomagnesemia (33%), edema (e.g., edema peripheral, edema, fluid overload, fluid retention, swelling face) (30%), decreased appetite (21%), hypokalemia (15%), weight loss (13%)[Ref]
Hepatic
- Very common (10% or more): AST increased (28%), alkaline phosphatase increased (23%)[Ref]
Respiratory
- Very common (10% or more): Dyspnea (e.g., dyspnea, hypoxia, bronchospasm, respiratory failure (23%), pneumonia (e.g., pneumonia, pneumonia aspiration, lung infection) (19%), cough (18%)[Ref]
Other
- Very common (10% or more): Asthenia/fatigue (36%), pyrexia (18%)[Ref]
Nervous system
- Very common (10% or more): Dysgeusia/ageusia (21%), dizziness (18%), headache (12%)[Ref]
Renal
- Very common (10% or more): Creatinine increased (96%), renal insufficiency (e.g., acute kidney injury, blood creatinine increased, oliguria, renal failure) (19%)[Ref]
Cardiovascular
- Very common (10% or more): Atrial arrhythmia (e.g., atrial fibrillation, bradycardia, tachycardia, sinus tachycardia) (13%), chest pain (e.g., chest pain, non-cardiac chest pain) (12%)
- Common (1% to 10%): QT interval prolongation[Ref]
Dermatologic
- Very common (10% or more): Rash (e.g., rash, pruritus, erythema, skin ulcer, rash maculopapular, rash pruritic (20%)
- Common (1% to 10%): Alopecia[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (29%), mucositis (e.g., mucosal inflammation, oropharyngeal pain, stomatitis, anal ulcer, gingival pain, laryngeal inflammation, esophagitis, oral pain, aphthous ulcer, mouth ulceration, pharyngeal inflammation) (21%), constipation (20%), diarrhea (18%), vomiting (18%)
- Common (1% to 10%): Loose tooth, toothache[Ref]
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Daunorubicin
Daunorubicin systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, acute ...
Revumenib
Revumenib systemic is used for acute lymphoblastic leukemia, acute myeloid leukemia, leukemia
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
References
1. (2018) "Product Information. Daurismo (glasdegib)." Pfizer U.S. Pharmaceuticals Group
Frequently asked questions
More about Daurismo (glasdegib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hedgehog pathway inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Daurismo side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.